Saturday, February 16, 2019

Health

Roche names Pao as Swiss R&D head after Reed exits

ZURICH (Reuters) - Swiss drugmaker Roche said it will put a cancer specialist at the helm of its Swiss-based research efforts in April,...

Ukrainian doctor struggles with lack of resources

KIEV (Reuters) - Family doctor Dmitriy Rozumiy struggles to bridge the gap between what his patients in rural Ukraine need and what the...

Eisai clinches Merck deal to develop and sell cancer drug, shares...

NEW YORK/TOKYO (Reuters) - Merck & Co Inc and Japan’s Eisai Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell...

Sanofi, Evotec team up for research on infectious diseases treatment

PARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added...

Roche names Pao head of drugs research and early development

ZURICH (Reuters) - Swiss drugmaker Roche named U.S. cancer expert William Pao head of its Pharma Research and Early Development (pRED) business after...

‘I spent my savings rather than wait for the NHS’

Hospital services are facing mounting pressure. Staff shortages, rising demand and a squeeze on budgets...

Check NHS cancer, A&E and operations targets in your area

The NHS is under severe pressure. Rising numbers of patients need hospital care - whether...

RECOMMENDED VIDEOS

POPULAR